ArticleJapanese journal of ophthalmology2026
Assessment of artifact-removed choriocapillaris flow voids in eyes with pachychoroid spectrum disorders.
Article in Japanese journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare choriocapillaris flow voids in pachychoroid spectrum disorders with an optical coherence tomography angiography (OCTA) image processing strategy excluding artifacts. STUDY
designRetrospective case-control study.
methodsThis study included 22 eyes with pachychoroid pigment epitheliopathy (PPE), 25 with spontaneously resolved central serous chorioretinopathy (CSC), 20 with photodynamic therapy (PDT)-treated CSC, 21 with active CSC, 19 with pachychoroid neovasculopathy (PNV) and 24 healthy eyes. The number, average area, and maximum area of flow voids and the percentage of nonperfused choriocapillaris area (PNPCA) were evaluated on artifact-removed binarized OCTA images using a custom MATLAB-powered algorithm.
resultsThe PNV group had the largest flow void maximum area, flow void average area, and PNPCA. After adjusting for covariates, PPE, active-CSC, and PNV were associated with increased PNPCA and with increases across all choriocapillaris flow-void parameters, whereas PDT-CSC was associated only with a larger maximum flow-void area. In pairwise comparisons, PNV showed a greater maximum flow-void area than other groups, and PNV had a higher average flow-void area than controls and spontaneously resolved CSC (p < 0.05). Pairwise comparisons showed no significant differences in the number of flow voids among the groups. The location of the maximum flow-void area was consistent with the location of pachyvessels (80%) and choroidal neovascularization (84.2%).
conclusionsFlow void parameters have higher values in pachychoroid eyes than in healthy controls. These parameters are worst in eyes with PNV. The maximum area of the choriocapillaris flow void, especially, may be a marker of focal ischemia and the tendency to development of PNV.
Indexed as
Identifiers
41854941What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.